Levothyroxine Sodium Anhydrous 500 ug / 5mL Injection 5 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 63323-0648-10 |
|---|---|
| Product NDC | 63323-0648 |
| Generic Drug Name | Levothyroxine Sodium Anhydrous |
| Brand Name | Levothyroxine Sodium |
| Manufacturer | Fresenius Kabi USA, LLC |
| Strength | 500 ug / 5mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial, Single-Dose |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-648-10) / 5 mL in 1 VIAL, SINGLE-DOSE |
| Active Ingredients | Levothyroxine Sodium Anhydrous |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Levothyroxine Sodium Anhydrous 500 ug / 5mL Injection is tracked under NDC 63323-0648-10 and rolls up into product family 63323-0648. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial, Single-Dose.
- Manufacturer: Fresenius Kabi USA, LLC.
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
This NDC appeared in documented shortage listings in 2019 and 2022, a recurring pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Levothyroxine Sodium Anhydrous in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Levothyroxine Sodium Anhydrous.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Levothyroxine Sodium Anhydrous 500 ug / 5mL Injection 5 mL, NDC 63323-0648-10, is a Fresenius Kabi USA, LLC 500 ug / 5mL injection presentation packaged as 1 Vial, Single-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 63323-0648-10.
- Digits-only NDC 11: 63323064810.
- Possible 10-digit display format: 63323-648-10 (6332364810).
Helpful product links
- Search by brand name: Levothyroxine Sodium.
- Exact NDC 11: 63323-0648-10.
- Product family NDC: 63323-0648.
- Compare related presentations: Levothyroxine Sodium Anhydrous 500 ug / 5mL Injection 5 mL.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.